Entera Bio (ENTX) Current Leases (2019 - 2026)
Entera Bio (ENTX) posted quarterly Current Leases of $185000.0 for Q1 2026, up 9.47% year-on-year from $169000.0 in Q1 2025, and down 19.57% on a QoQ basis from $230000.0 in Q4 2025.
Entera Bio (ENTX) Current Leases (2019 - 2026) Analysis & Trends
Entera Bio (ENTX) has reported Current Leases for 8 consecutive years, with $185000.0 the latest figure, recorded in Q1 2026.
- Quarterly Current Leases rose 9.47% year-over-year to $185000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $185000.0 (up 9.47% YoY) and the FY2025 annual result came in at $230000.0, up 35.29% from the prior year.
- Current Leases retreated to $185000.0 in Q1 2026 per ENTX's latest filing, from $230000.0 in the prior quarter.
- Over the last five years, Current Leases for ENTX reached as high as $230000.0 in Q4 2025 and fell as low as $48000.0 in Q1 2023.
- A 5-year average of $151470.6 and a median of $155000.0 in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases tumbled 66.2% — and 2024, when it surged 218.75%.
- Year by year, Current Leases stood at $91000.0 in 2022, then jumped by 47.25% to $134000.0 in 2023, then rose by 26.87% to $170000.0 in 2024, then soared by 35.29% to $230000.0 in 2025, then declined by 19.57% to $185000.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $185000.0, $230000.0, and $170000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.61 Mn |
| 10 | Entera Bio | 186.78 Mn | 182.64 Mn | - | 185,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 185,000.00 |
| Dec 31, 2025 | 230,000.00 |
| Sep 30, 2025 | 170,000.00 |
| Jun 30, 2025 | 194,000.00 |
| Mar 31, 2025 | 169,000.00 |
| Dec 31, 2024 | 170,000.00 |
| Sep 30, 2024 | 162,000.00 |
| Jun 30, 2024 | 155,000.00 |
| Mar 31, 2024 | 153,000.00 |
| Dec 31, 2023 | 134,000.00 |
| Sep 30, 2023 | 131,000.00 |
| Jun 30, 2023 | 140,000.00 |
| Mar 31, 2023 | 48,000.00 |
| Dec 31, 2022 | 91,000.00 |
| Sep 30, 2022 | 129,000.00 |
| Jun 30, 2022 | 172,000.00 |
| Mar 31, 2022 | 142,000.00 |
| Dec 31, 2021 | 179,000.00 |
| Jun 30, 2021 | 184,000.00 |
| Dec 31, 2020 | 189,000.00 |